Germline mutation of BRIP1 has been show to increase the risk of hereditary ovarian cancer [29], although the BRIP1 NECC mutation we observed was not clearly pathogenic and that tumor did not exhibit mutational signatures consistent with a defect in homologous recombination. This evidence concerns the gene BRIP1 and ovarian cancer.